| Integrated molecular characterization of testicular germ cell tumors H Shen, J Shih, DP Hollern, L Wang, R Bowlby, SK Tickoo, V Thorsson, ... Cell reports 23 (11), 3392-3406, 2018 | 365 | 2018 |
| B cells and T follicular helper cells mediate response to checkpoint inhibitors in high mutation burden mouse models of breast cancer DP Hollern, N Xu, A Thennavan, C Glodowski, S Garcia-Recio, KR Mott, ... Cell 179 (5), 1191-1206. e21, 2019 | 339 | 2019 |
| Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation SY Lunt, V Muralidhar, AM Hosios, WJ Israelsen, DY Gui, L Newhouse, ... Molecular cell 57 (1), 95-107, 2015 | 246 | 2015 |
| NMDA receptor-mediated excitotoxicity depends on the coactivation of synaptic and extrasynaptic receptors X Zhou, D Hollern, J Liao, E Andrechek, H Wang Cell death & disease 4 (3), e560-e560, 2013 | 230 | 2013 |
| Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities CM Laumont, AC Banville, M Gilardi, DP Hollern, BH Nelson Nature Reviews Cancer 22 (7), 414-430, 2022 | 160 | 2022 |
| The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancer DP Hollern, J Honeysett, RD Cardiff, ER Andrechek Molecular and cellular biology 34 (17), 3229-3243, 2014 | 127 | 2014 |
| A genomic analysis of mouse models of breast cancer reveals molecular features ofmouse models and relationships to human breast cancer DP Hollern, ER Andrechek Breast Cancer Research 16, 1-16, 2014 | 90 | 2014 |
| E2F1 drives breast cancer metastasis by regulating the target gene FGF13 and altering cell migration DP Hollern, MR Swiatnicki, JP Rennhack, SA Misek, BC Matson, ... Scientific reports 9 (1), 10718, 2019 | 69 | 2019 |
| Histological subtypes of mouse mammary tumors reveal conserved relationships to human cancers DP Hollern, MR Swiatnicki, ER Andrechek PLoS genetics 14 (1), e1007135, 2018 | 66 | 2018 |
| FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease S Garcia-Recio, A Thennavan, MP East, JS Parker, JM Cejalvo, JP Garay, ... The Journal of clinical investigation 130 (9), 4871-4887, 2020 | 62 | 2020 |
| FOXA1 overexpression suppresses interferon signaling and immune response in cancer Y He, L Wang, T Wei, YT Xiao, H Sheng, H Su, DP Hollern, X Zhang, J Ma, ... The Journal of clinical investigation 131 (14), 2021 | 59 | 2021 |
| Cdh1 and Pik3ca mutations cooperate to induce immune-related invasive lobular carcinoma of the breast Y An, JR Adams, DP Hollern, A Zhao, SG Chang, MS Gams, PED Chung, ... Cell reports 25 (3), 702-714. e6, 2018 | 58 | 2018 |
| Prediction and genetic demonstration of a role for activator E2Fs in Myc-induced tumors K Fujiwara, I Yuwanita, DP Hollern, ER Andrechek Cancer research 71 (5), 1924-1932, 2011 | 52 | 2011 |
| Stimulation of oncogene-specific tumor-infiltrating T cells through combined vaccine and αPD-1 enable sustained antitumor responses against established HER2 breast cancer EJ Crosby, CR Acharya, AF Haddad, CA Rabiola, G Lei, JP Wei, XY Yang, ... Clinical Cancer Research 26 (17), 4670-4681, 2020 | 36 | 2020 |
| Virus expression detection reveals RNA-sequencing contamination in TCGA SR Selitsky, D Marron, D Hollern, LE Mose, KA Hoadley, C Jones, ... BMC genomics 21, 1-11, 2020 | 29 | 2020 |
| Chemotherapy coupled to macrophage inhibition induces T-cell and B-cell infiltration and durable regression in triple-negative breast cancer S Singh, N Lee, DA Pedroza, IL Bado, C Hamor, L Zhang, S Aguirre, J Hu, ... Cancer research 82 (12), 2281-2297, 2022 | 25 | 2022 |
| Microneedle-mediated intratumoral delivery of anti-CTLA-4 promotes cDC1-dependent eradication of oral squamous cell carcinoma with limited irAEs M Gilardi, R Saddawi-Konefka, VH Wu, MA Lopez-Ramirez, Z Wang, ... Molecular cancer therapeutics 21 (4), 616-624, 2022 | 24 | 2022 |
| A mouse model with T58A mutations in Myc reduces the dependence on KRas mutations and has similarities to claudin-low human breast cancer DP Hollern, I Yuwanita, ER Andrechek Oncogene 32 (10), 1296-1304, 2013 | 24 | 2013 |
| A mouse model featuring tissue-specific deletion of p53 and Brca1 gives rise to mammary tumors with genomic and transcriptomic similarities to human basal-like breast cancer DP Hollern, CM Contreras, S Dance-Barnes, GO Silva, AD Pfefferle, ... Breast cancer research and treatment 174, 143-155, 2019 | 23 | 2019 |
| NCOA5 deficiency promotes a unique liver protumorigenic microenvironment through p21WAF1/CIP1 overexpression, which is reversed by metformin M Williams, X Liu, Y Zhang, J Reske, D Bahal, TG Gohl, D Hollern, ... Oncogene 39 (19), 3821-3836, 2020 | 19 | 2020 |
